A full description of Falanx Group Limited’s business can be found on here.

Falanx Group is listed on the AIM market of the London Stock Exchange and therefore provides the following information in adherence to AIM Rule 26:

Country of incorporation and main country of operation:

Country of Incorporation: British Virgin Islands.
Note as the company is not incorporated in the UK, the rights of shareholders may be different from the rights of shareholders in a UK incorporated company.

The company is not subject to and does not follow the UK Take Over Code.

Main Country of Operation: United Kingdom

The Group’s Registered Office is:

Falanx Group, The Blade, Abbey Square, Reading, RG1 3BE, United Kingdom. The Group’s BVI address is PO Box 173, MAPLES CORPORATE SERVICES (BVI) LTD, Kingston Chambers Road Town, Tortola, Virgin Islands, British.

UK Companies House Reference: FC031798

BVI Reference Number: 1730012

Download Admission Document

Falanx has no restrictions on the transfer of its AIM securities.

Information regarding other exchanges / trading platforms that the AIM company has applied / agreed to have its securities (stock or bonds) admitted / traded:

Falanx Group shares are solely traded on the Alternative Investment Market of the London Stock Exchange. None of the Company’s securities are admitted to trading on any exchange or trading platform other than AIM. There have been no applications for any such admission.

The number of AIM securities in issue (noting any held as treasury shares) and, insofar as it is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders. This information should be updated at least every 6 months.

The number of Ordinary Shares in issue total: 400,401,185

The Company does not hold any shares in treasury.

Key Stakeholders

Updated: 27/07/2020

Registered holder Number of Ordinary Shares Percentage of Enlarged Number of Shares the Company is authorised to issue
Octopus Investments Nominees Limited 50,000,000 12.49%
Amati AIM VCT plc 45,000,000 11.24%
Unicorn VCT 33,333,333 8.32%
Miton Group PLC 32,554,339 8.13%
Michael David Read (Director) 11,813,940 2.95%
Alex Hambro (Director) 1,250,000 0.31%
Ian Selby (Director) 1,069,348 0.27%
Emma Shaw (Director) 866,666 0.22%

Total number of Shares in issue 400,401,185
Shares not in public hands 27.47%
Updated 10th January 2020.
Nominated Adviser and Joint Broker Stifel Nicolaus Europe Limited
50 Cheapside
 Joint Broker Turner Pope Investments (TPI) Limited
6th Floor
Becket House
36 Old Jewry
Solicitors to the Company as to English Law DWF LLP
1 Scott Place
2 Hardman Street
M3 3AA
Legal Advisers to the Company as to BVI Law Maples & Calder
11th Floor
200 Aldersgate Street

55 Baker St

Registrar Computershare Investor Services (BVI) Limited
Woodbourne Hall
PO Box 3162
Road Town
British Virgin Islands
Financial PR IFC Advisory Limited, 15 Bishopsgate, London EC2N 3AR
Company’s website www.falanx.com

Board Composition

The Board is responsible for formulating, reviewing and approving the Company’s strategy, budgets and corporate actions, identification of risks and implementation of internal controls. The Company intends to hold Board meetings at least eight times each financial year and at other times as and when required. It will comprise of the Executive Chairman, the Chief Executive Officer, the Chief Financial Officer and two further Non-Executive Directors, at least one of whom is deemed independent.

The Board considers that it has an appropriate blend of skill and experience and will implement a process of performance evaluation and development.

The Board will disclose to the Company’s Shareholders in its annual report or on its website its objectives and strategy, the principal risks facing the Group and the internal controls adopted to address such risks and how the Company proposes to fulfill its corporate governance objectives.

Meet the Falanx Group Board

For more information, please call +44 (0) 20 7856 9450 or fill out the contact form below.